Sales decline 15.75% to Rs 338.37 crore
Net loss of Solara Active Pharma Sciences reported to Rs 9.96 crore in the quarter ended September 2022 as against net profit of Rs 29.71 crore during the previous quarter ended September 2021. Sales declined 15.75% to Rs 338.37 crore in the quarter ended September 2022 as against Rs 401.61 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales338.37401.61 -16 OPM %8.1517.89 -PBDT9.3358.14 -84 PBT-19.3029.76 PL NP-9.9629.71 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
